Help optimize lung health in people with HIV through pharmacist e-consults
Part of Infections, Lungs & breathing clinical trials.
This trial tests whether a pharmacist-led electronic consultation can improve medication use and lung health in people with HIV. It focuses on those who smoke or use certain medications like inhaled steroids or acid reflux pills.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have HIV and have been on antiretroviral therapy for at least 6 months.
- You receive your care at a VA hospital or clinic.
- You currently smoke cigarettes or have been prescribed an inhaled steroid or a proton pump inhibitor for more than 90 days.
- You are not enrolled in palliative care or hospice.
- Your main primary care or HIV doctor is not from outside the VA.
- You are not currently in another interventional clinical trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a harm-reduction approach to help people with HIV smoke fewer cigarettes and quit if they want, using an online tobacco program and varenicline (a quit-smoking medicine). You may be placed in one of two different study groups to compare how well the approaches work.
This study works with pharmacists at six Ryan White HIV clinics to help people with HIV quit smoking or using tobacco. If you have HIV, are 21 or older, and have already met with a pharmacist about tobacco, you may be able to join.
This trial tests ways to deliver tobacco-quit treatment more effectively for people living with HIV. You may help researchers compare different quit-support approaches to see what works best.
This trial tests smoking-cessation interventions to help people living with HIV quit smoking or smoke less. You may be eligible if you smoke, are actively engaged in HIV treatment, and can follow the study for about a year.
This study looks at how a specific e-cigarette affects health in people who have HIV and smoke cigarettes regularly. You might be able to join if you meet smoking, HIV care, and safety requirements and are not planning to quit right away.
This study supports quitting smoking while you are receiving HIV and/or TB care. It aims to improve engagement in care and smoking cessation for people who smoke daily.
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.